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Venous reconstructions using the 
superficial femoral-popliteal vein 
Ryan T. Hagino,  MD, Todd D. Bengtson, MD, David A. Fosdiek, MD, 
R. James Valentine, MD,  and G. Patrick Clagett, MD, Dallas, Tex. 
Purpose: To demonstrate he feasibility of venous reconstructions with the superficial 
femoral-popliteal vein (SFPV). 
Methods: Seven patients who underwent a variety of major venous reconstructions using 
SFPV were reviewed in a retrospective, observational study. 
Results: Three central venous reconstructions (thoracic and abdominal) and fore" periph- 
eral major venous reconstructions were performed with SFPV autografts. In all patients, 
the SFPV grafts provided an excellent size match and were of adequate l ngth without 
the need for enlargement by paneling or spiraling techniques. Postoperative anticoagula- 
tion medication was not used. There were no early graft failures, and patency was 
documented by duplex ultrasound, venogram, or both in all patients at a mean of  20 
months follow-up. Venous thromboembol ism has not occurred, and lower extremity 
venous morbidity has been minimal. 
Conclusions: The SFPV graft demonstrates versatility and durability in selected patients 
who require large-caliber conduits for venous reconstruction. Because of  its size and 
availability, the SFPV is an excellent conduit for major venous reconstruction. (J Vasc 
Surg 1997;26:829-37.) 
Major venous reconstructions are compromised 
by the lack of nonthrombogenic, large-caliber con- 
duits that will remain patent in the low-pressure, 
low-velocity venous system. 1,2 The wide availability 
of polytetrafluoroethylene (ePTFE) prostheses in 
large diameters has led many investigators to recom- 
mend these as conduits for venous bypass grafting. 3-7 
Patency rates of prosthetic venous bypass grafts range 
from 50% to 100% at 5.5- to 60-month follow- 
upfi -11 However, acceptable graft longevity requires 
the use of external supporting tings, proximal arte- 
riovenous fistulae, chronic anticoagulation, anti- 
platelet herapy, or a combination of these. The an- 
tologous spiral vein graft fashioned from greater 
saphenous vein has demonstrated xcellent patency, 
particularly when used to reconstruct nonmalignant 
occlusive disease of the superior x(ena cava (SVC) and 
branches. 1°-~3 Unfortunately, the technique can be 
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time-consuming and technically demanding. In ad- 
dition, the lack of  a suitable length and quality of 
greater saphenous vein may confound attempts at 
creating a spiral conduit. 
The superficial femoral-popliteal vein (SFPV) has 
been used as a conduit for in situ aortoiliofemoral 
arterial reconstruction after' aortic prosthetic graft 
infection with excellent long-term results. 1416 Pa- 
tency in these arterial reconstructions has been 
unencumbered by late graft dilation or stenosis. 
The ready availability of  long segments of  this 
large-diameter vein makes it an  ideal autologous 
conduit for these complex problems. We have also 
used the SFPV for major venous reconstructions. 
For the same reasons of  availability, durability, 
size, and length, we believe the SFPV is an ideal 
conduit for venous reconstruction. The purpose of  
this study was to document the feasibility and 
durability of  the SFPV graft in a heterogenous 
group of  major venous reconstructions. 
METHODS 
All major venous reconstructions that required 
bypass grafting during the past 5 years were per- 
formed using SFPV. Inpatient records, vascular lab- 
oratory studies, and outpatient clinic charts were 
reviewed. Follow-up was established through medi- 
cal records, telephone interviews, and clinic visits. 
Graft patency was established using noninvasive test- 
829 
JOURNAL OF VASCULAR SURGERY 
830 Hagino et aL November 1997 
Table I. Venous reconstructions 
Patient Age 
no. (yr)/sex Presentation Cause Reconstruction 
Graft Donor limb 
diameter venous 
(mm) Patency/study Clinical result morbidity 
1 46/M SVC syndrome Epithefial Bilateral IV-RAA 
hemangioendotheiioma 
2 62/F SVC syndrome Thymoma Left IV-RAA 
3 37/M Acute renal Iatrogenic renal vein Left renal vein- 
failure injury IVC 
4 64/M Recurrent Bilateral radical neck Left IJV 
squamous cell dissections interposition 
carcinoma 
5 26/M Left SCV Percutaneous dialysis Left axillary-IJV 
thrombosis catheter 
6 6/F Intracranial Dural arteriovenous Sagittal/transverse 
venous malformation sinus-right IJV 
hypertension 
7 18/M Right CFV injury Gunshot wound Right SFV-CFV 
12 34 mo/duplex Asymptomatic None 
10 3 too/duplex Improved None 
15 54 too/duplex Asymptomatic None 
10 14 days/duplex Improved None 
10 13 mo/duplex Asymptomatic None 
5 21 days/ Improved None 
venogram 
12 37 mo/duplex Asymptomatic None 
IV, Innominate veins; RAA, right atrial appendage; IVC, inferior vena cava; IJV, internal jugular vein; SCV, subclavian vein; SFV, 
superficial femoral vein; CFV, common femoral vein. 
ing, invasive contrast studies, or both. Functional 
results were documented on a case-by-case basis. 
The technique of harvesting the SFPV has been 
previously described, 14 but will be briefly reviewed 
here. Preoperative lower extremity venous duplex 
examination is used to confirm the size and patency 
of  the SFPV. Additional information, such as scar- 
fing and recanalization after prior thrombosis or the 
presence of duplications or congenital hypoplasia 
with dominant profunda femoral venous drainage, 
can be invaluable in planning an appropriate opera- 
tion. A longitudinal inclsion made over the lateral 
border of the sartorius muscle allows wide exposure 
of the SFPV. The adductor canal is exposed along its 
length by medial retraction of the sartorius muscle. 
The SFPV is found posterolateral to the superficial 
femoral artery and is isolated with a vessel loop. 
Meticulous dissection allows individual ligation of 
the numerous branches. Proximal dissection is car- 
ried to the junction of the SFPV with the profunda 
femoral vein. Distal dissection is varied according to 
the length of  conduit required for  the reconstruc- 
tion. If  necessary, the insertion of the adductor mag- 
nus can be divided, the adductor hiatus opened, and 
the dissection carried onto the popliteal vein. Care 
must be tal<en to preserve the saphenous nerve, 
which runs parallel to the SFPV in Hunter's canal. 
Injury can result in a temporary, but annoying, neu- 
ralgia. When an appropriate length of conduit is 
established, the proximal SFPV is divided flush with 
the profunda femoral vein and oversewn with 
polypropylene monofilament. Distal ligation is per- 
formed with permanent suture ligature. After hemo- 
stasis is achieved, the vein harvest site is closed with- 
out drainage in multiple layers using absorbable 
suture. In the postoperative period, aggressive pro- 
phylaxis against deep venous thrombosis i initiated 
using subcutaneous heparin and intermittent pneu- 
matic compression. 
RESULTS 
Patients and results are summarized in Table I. 
Central (abdominal and thoracic) venous 
reconstructions 
Case 1. A 46-year-old man had a mediastinal 
mass noted on routine chest roentgenogram. A com- 
puted tomogram (CT) of  the chest confirmed the 
presence of a mass in the right pretracheal space 
behind the right innominate vein, and biopsy dem- 
onstrated a malignant epithelial hemangioendotheli- 
oma. The mass was resected en bloc with the distal 
right and left innominate veins and SVC. Recon- 
struction of the great veins was achieved using an 
SFPV graft placed between the right and left innom- 
inate veins and the right atrium (Fig. 1). Central 
venous pressures of  25 to 30 mm Hg decreased to 
normal after the bypass procedure. Color flow du- 
plex ultrasound examination confirmed a patent by- 
pass graft 34 months after implantation without the 
use of chronic anticoagulation medication. He re- 
mains free of  tumor recurrence and has not had 
lower extremity swelling or venous morbidity 3 years 
after operation. 
Case 2. A 62-year-old woman with a previously 
irradiated, poorly ditiErentiated thymoma was admit- 
ted with progressive postural dyspnea, cough, and 
facial swelling. The chest CT is pictured in Fig. 2. 
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The preoperative venogram confirmed SVC occlu- 
sion (Fig. 3). On exploration through amedian ster- 
notomy, the tumor and associated severe fibrotic 
reaction were found to be encasing a thrombosed 
SVC and right innominate vein. After tumor resec- 
tion, a 14 cm length of SFPV was harvested, and a 
left innominate-to-right a rial bypass graft was 
placed. The vein graft, when gently distended, mea- 
sured 10 mm in diameter, providing an adequate size 
match with the innominate vein remnant. The pa- 
tient's postoperative course was complicated by re- 
spiratory failure and gastrointestinal bleeding. A du- 
plex examination 3 months after the operation 
demonstrated a patent mediastinal bypass graft, and 
the patient has had no lower extremity venous mor- 
bidity. 
Case 3. A 37-year-old man had acute renal fail- 
ure after a right nephrectomy for complications of 
polycystic lddney disease. This operation was compli- 
cated by the unrecognized ligation and division of 
the left renal vein. Exploration confirmed a 2- to 
3-cm gap°oetween the distal end of the left renal vein 
and the inferior vena c~iva. After thrombectomy, pri- 
mary reanastomosis was not feasible because ofretro- 
peritoneal edema and renal swelling. A left renal 
vein-to-inferior vena cava bypass graft using SFPV 
was placed. The 15 mm diameter SFPV provided an 
excellent size match with the left renal vein. Return 
of renal function was immediate, and hemodialysis 
was discontinued. This case has been previously re- 
ported, 17 and longer follow-up is now available. The 
patient continues to do well with normal renal func- 
tion; duplex examination demonstrated patency 54 
months after reconstruction without the use of 
chronic anticoagulant or antiplatelet therapy. He had 
transient donor limb swelling treated with 30 to 40 
mm Hg compression for approximately 6 months. 
Peripheral venous reconstructions 
Case 4. A 64-year-old man had recurrent squa- 
mous cell carcinoma of the left neck. Ten months 
earlier, he had undergone a partial glossectomy and 
left modified radical neck dissection with adjuvant 
radiotherapy for squamous cell carcinoma of the 
tongue. Simultaneous bilateral radical neck dissec- 
"tions were performed, and the left internal jugular 
vein was reconstructed using a 10 mm diameter 
SFPV harvested from the left thigh. Early patency 
was confirmed at 14 days by duplex ultrasonography, 
and the patient died 2 months after resection from 
metastatic disease. 
Case 5. A 26-year-old man with end-stage renal 
disease had been plagued by multiple dialysis arterio- 
Fig. 1. Bilateral innominate vein-to-right atrial append- 
age bypass graft using SFPV. 
venous graft failures. Upper extremity and lower 
extremity dialysis grafts had failed after repeated 
thrombectomies and revisions. In addition, multiple 
temporary subclavian dialysis catheters had been 
placed. The patient returned 17 months after place- 
ment of a left upper arm brachial artery-to-axillary 
vein ePTFE loop with severe upper extremity swell- 
ing, cyanosis, and pain while on hemodialysis. A 
venogram confirmed a thrombosed left subclavian 
vein. Using both supraclavicular nd infraclavicular 
incisions, a left axillary vein-to-left internal jugular 
vein bypass graft was constructed using the right 
SFPV (Fig. 4). Symptomatic relief was immediate, 
and venous pressures during dialysis returned to nor- 
real. The ePTFE loop thrombosed i 1 months later, 
and cadaveric renal transplant was performed. This 
was complicated by hemorrhagic pancreatitis, epsis, 
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Fig. 2. Chest CT scan demonstrates tumor mass encasing a thrombosed SVC (arrow). 
and multiple organ failure, and the patient died 2 
months after transplantation. Interestingly, a venous 
duplex examination performed 1 month before 
death revealed awidely patent axillo-internal jugular 
vein bypass graft despite the thrombosed arterio- 
venous loop. 
Case 6. A &year-old girl had a dural arterio- 
venous malformation (AVM) draining into the supe- 
rior sagittal sinus and a thrombosed cavernous inus. 
Despite initial control with endovascular embolo- 
therapy, progressive severe headaches, papilledema, 
and refractory seizures ensued over a 12-month pe- 
riod. A repeat arteriogram revealed revascularization 
of the dural AVM. Status epilepticus developed, and 
the patient was responding only to pain. Emergent 
ventticulostomy confirmed markedly elevated intra- 
cranial pressures. Further attempts with embolo- 
therapy, ventriculoperitoneal shunting, and craniec- 
tomy with temporal lobe resection were unsuccessful 
in relieving cerebral edema. In an attempt o control 
her cerebral venous hypertension, a superior sagittal 
sinus-to-right internal jugular bypass procedure 
with a SFPV graft was performed. On preoperative 
duplex scan, her greater saphenous veins were small 
(2 mm), but both SFPVs were of adequate diameter 
(5 to 6 mm) for bypass grafting. Cerebral swelling 
decreased, and a postoperative angiogram performed 
3 weeks after bypass grafting demonstrated a widely 
patent venous bypass graft (Fig. 5). One month after 
the bypass procedure, the patient died during at- 
tempted repair of an associated ural cerebrospinal 
fluid leak. 
Case 7. An 18-year-old man had a gunshot 
wound to the right groin and profuse bleeding. 
Emergent exploration demonstrated a complex com- 
mon femoral vein injury involving the confluence of 
the profunda and superficial femoral veins. The con- 
tralateral SFPV was used to reconstruct the femoral 
vein bifurcation, with an interposition graft between 
the right SFPV and the common femoral vein (Fig. 
6). The right profunda femoral vein was ligated. A 
postoperative duplex examination confirmed a 
patent reconstruction and an excellent size match 
between the graft and the common femoral vein. 
Oral anticoagulation medication was not used. A late 
duplex follow-up study performed at 37 months re- 
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Fig. 3. Venogram demonstrates occlusion of SVC in a patient with a poorly differentiated 
thymoma.  
Fig. 4. Left axillary vein-to-internal jugular venous bypass graft. 
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Fig. 5. Venous phase ofthis cerebral arteriogram de on- 
strates a widely patent superior sagittal sinus-to-right in- 
ternal jugular vein bypass graft using SFPV 3 weeks after 
implantation. 
vealed a widely patent graft, and no long-term swell- 
ing, sldn changes, or venous symptoms have devel- 
oped. 
DISCUSSION 
Major venous reconstructions with the SFPV 
have been previously reported. In 1951, Klassen and 
colleagues 18 first described its use to bypass SVC 
obstruction in a 26-year-old patient with flbrosing 
mediastinitis from anthracosis. Scattered reports l -22 
over the past five decades reflect a sporadic experi- 
ence with SFPV bypass grafting for relief of SVC 
syndrome (Table II). Versatile applications ranged 
from simple bypass grafting and proximal azygos- 
SVC shunt o the use of a pantaloon bifurcated graft 
from both innominate veins to the atrial appendage. 
Although follow-up was variable (8 days to 8.5 
years), late venograms were available in the majority 
of patients; all venograms demonstrated patent, 
functioning rafts 3 to 42 months after implantation. 
Despite the success and longevity of these bypass 
grafts in treating SVC syndrome, the use of SFPV as a 
venous bypass conduit has never become popular. 
Perhaps this reluctance is based on fears of excessive 
venous morbidity in the donor limb and difficulty in 
harvesting the autograft. Recent experience with ar- 
terial reconstructions u ing SFPV has documented a 
lack of serious venous morbidity associated with re- 
Fig. 6. Venous reconstruction f left common femoral 
vein using contralateral SFPV. The graft was interposed 
between the superficial femoral vein and the common 
femoral vein. The profunda femoral vein was ligated. 
moval of the deep vein. 14-16 Therefore, wider appli- 
cation of these grafts can be anticipated. 
The two patients we treated for SVC syndrome 
with SFPV bypass procedures remain without symp- 
toms, with graft patency confirmed by color flow 
duplex ultrasound at 3 and 34 months. Patency was 
not facilitated by the use of oral anticoagulant medi- 
cations or temporary arteriovenous fistulae. These 
results compare favorably with those obtained with 
reconstructions using spiral saphenous vein grafts 
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Table I I .  Published cases of SVC reconstruction with SFPV 
No. of 
Author/year patients Cause  Reconstruction Objective patency/study Clinical outcome/follow-up 
Klassen et al./195118 
Scannel et al/195419 
Hanlon et al./19652° 
Gladstone t al./1985 a~ 
Marshall et al./19882z 
1 Anthracosis Azygos-SVC 5 mo/venogram 
2 Radiation fibrosis Right IJV4VC 8 days/autopsy 
Organized traumatic Right IJV-RAA 3 mo/venogram 
hematoma 
2 Inflammatory mass Right W/left IV-SVC 42 mo/venogram 
Mediastinal sarcoma Left IV-RAA None 
2 Idiopathic fibrosing Right IJV-SVC 12 mo/venogram 
mediastinitis 
Poorly differentiated Left IV-SVC None 
carcinoma 
1 Failed spiral vein Left IV-RAA 24 mo/venograna 
graft 
Asympatomatic/5 mo
Died of mediastinitis 
Asympatomatic/12 mo 
Asymptomatic/8.5 yr 
Asymptomatic/5 yr 
Asymptomatic/12 mo
Asymptomatic/9 mo 
Asymptomatic/24 mo
IJV~ Internal jugular vein; RAA, right atrial appendage; IV, innominate v in. 
(SSVGs) and ePTFE for relief of SVC obstruction. 4- 
8,10-13 In addition, the reports of Doty and col- 
leagues ~2,1a relate SSVG diameters that range from 9 
to 15 mm constructed over 28F to 40F chest tube 
stents. We reported that the average diameter of 41 
SFPVs used for in situ aortic reconstruction was 
10.2 + 1.9 ram. 14 Most of the grafts in the current 
study were 10 mm or larger in diameter. As a result, 
SFPV provides a comparable size match with SSVG 
without the need for complicated spiraling and is 
readily available in lengths adequate for longer by- 
pass grafts. 
The SSVG is not as durable as ePTFE bypass 
grafts for intraabdominal venous reconstruction. 1°,11 
The inferior patency rate may be related to problems 
with patient selection, competitive flow through 
large venous collateral vessels, or the length of a 
compressible conduit exposed to intraabdominal 
pressure. These factors favor occlusion of SSVG by- 
pass grafts in the abdomen. We have successfully 
used the SFPV to replace the left renal vein. Renal 
function was preserved, and the graft remains patent 
despite the lack of chronic anticoagulanon or anti- 
platelet therapy, exposure to intraabdominal ,pres- 
sure, and the weight of  the abdominal viscera. How- 
ever, the possibility of using longer intraabdominal 
vein bypass grafts with SFPV for durable relief of 
vena cava or iliac vein obstruction requires explora- 
tion. The availability of long segments of SFPV that 
are capable of bypassing the entire infrarenal vena 
cava to the femoral level may prove invaluable in 
reconstructing anatomically remote sites. 
Palliative internal jugular vein reconstruction af- 
ter bilateral radical neck dissection for malignancy in 
which both jugular veins are sacrificed remains con- 
troversial. 9,23,24 Massive facial edema is common, but 
the distinction between lymphatic congestion and 
venous hypertension as the cause of the swelling is 
unclear. Staged resection may allow venous or lym- 
phatic collateral vessels time to develop, but this is 
less desirable from an oncologic perspective. Regard- 
less of the precise origin, the edema is associated with 
considerable morbidity and may be severe nough to 
cause intracranial hypertension and death. Conse- 
quently, jugular venous reconstruction has been ad- 
vocated in patients who require bilateral radical neck 
dissections to reduce venous hypertension and re- 
lated complications. 9,23,24 The experience of Com- 
erota et al.9 confirmed that carefully selected patients 
with venous hypertension determined by venous 
stump pressure measurements will benefit from uni- 
lateral internal jugular vein interposition grafting. 
Their overall patency rate was 64% with 2 to 18 
months of follow-up. The majority of graft failures 
occurred in bypass grafts that were created using 
ePTFE. SFPV internal jugular eplacement is a useful 
option for simultaneous bilateral radical neck dissec- 
tion that requires bilateral jugular vein resection. 
Successful internal jugular reconstruction using 
SFPV has been reported by others .  2&24 The SFPV 
graft more closely approximates the diameter of the 
internal jugular vein than a saphenous vein graft. 
This size match allows autologous reconstruction i  
contaminated fields. 
Central venous stenosis of the axillosubclavian 
veins in patients who are undergoing chronic hemo- 
dialysis is common. 25 The frequent placement of 
large-caliber dialysis access catheters in the subclavian 
veins is the cause of this problem. 3,2~,26 The longev- 
ity of upper extremity hemodialysis arteriovenous 
shunts and fistulae may be reduced by outflow steno- 
sis or occlusion of  the subclavian veins. In addition, 
asymptomatic subclavian obstructions can result in 
venous hypertension and upper extremity phlegma- 
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sia after placement of chronic arteriovenous angioac- 
cess in the affected arm. The recognition of these 
stenoses as a cause for dialysis graft failure and upper 
extremity edema prompted the development ofvari- 
ous techniques to correct he stenoses or circumvent 
them. a,6,26-28 As our case demonstrates, these pa- 
tients have exhausted multiple access ites, and pres- 
ervation of functioning dialysis access remains an 
important priority. Endovascular interventions with 
intraluminal stent placement within the subclavian 
vein compare favorably with surgical bypass proce- 
dures. 26 However, when percutaneous techniques 
fail, surgical bypass grafting may be the only option 
in salvaging the dialysis access. Internal jugular vein- 
to-subclavian vein transposition has the advantages 
of being all-autologous and requiring only one anas- 
tomosis. 27,28 However, we favor SFPV graft interpo- 
sition grafting to this procedure because it allows 
preservation of the internal jugular vein for venous 
access in the future and may have better patency 
rates. The size match between the SFPV and the 
subclavian vein is excellent, allowing creation of a 
large venous outflow tract without he use of pros- 
thetic material. 
The multitude of venous obstructive syndromes 
is reflected in the great variety of venous reconstruc- 
tions. Treatment options must be individualized to 
meet specific anatomic and physiologic onditions. 
In this regard, the versatility of the SFPV as venous 
conduit is its great strength. The unusual case of 
cavernous inus thrombosis and dural arteriovenous 
malformation typifies the need for adaptability. Sag- 
ittal sinus-to-jugular bypass grafting with saphenous 
vein grafts has been used successfully in Japan and 
France to reduce intracerebral pressure in patients 
who have cavernous sinus thrombosis. 29,3° The 
young age and small greater saphenous veins in our 
patient necessitated the use of SFPV for venous by- 
pass grafting. The size and length proved ideal for 
this purpose. 
The frequent early failure of interposition saphe- 
nous vein grafts used for repair of traumatic venous 
injuries remains a problem; early failures are esti- 
mated to occur in 59% to 75% of grafts within the 
first week. 31,32 Some have attributed these failures to 
a lack of suitable conduit of adequate diameter. 33,34 
Aitken et al?3 have even suggested that panel saphe- 
nous vein grafts should be attempted in all patients 
who have major venous injuries. The use of SFPV 
autografts in the reconstruction of traumatic venous 
injuries has not been previously described. In our 
case, the contralateral SFPV provided an excellent 
large-diameter conduit for common femoral vein re- 
construction. We thought hat ligation alone would 
have severely impaired the venous outflow to the 
lower extremity because of the location and magni- 
tude of the injury. The SFPV was readily available 
and was harvested without significant added opera- 
five time. 
The applications of SFPV grafts as alternative 
conduit for arterial reconstructions have been widen- 
ing. Long-term objective follow-up has supplanted 
anecdotal reports of minimal lower extremity venous 
morbidity after removal of the SFPV. 14"16,35,36 The 
lack of significant late venous welling and symptoms 
have increased the enthusiasm for the use of this vein 
as acceptable autologous conduit. The broad applica- 
tion of major venous reconstruction with SFPV 
grafts in our patients attests to the versatility of the 
conduit. Unfortunately, this versatility may have sig- 
nificant limitations. Patients who are plagued by ob- 
structive iliofemoral venous disease and postphlebitic 
changes from chronic deep venous thrombosis n the 
axial veins of the lower limb may experience severe 
donor limb morbidity after removal of the SFPV. 
Therefore, we do not recommend removing the 
SFPV in patients who have chronic lower extremity 
venous insufficiency. 
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